3. Criteria
carcinoma
CARCINOMA, SENSORY POLYNEUROPATHY, COAGULATION DISORDER, CALCAR CALCANEI, OSTEOPOROSIS
A total of 190 patients were considered for the study, of whom 124 fulfilled the criteria for inclusion. The primary criterion for including patients in the study was diagnostically confirmed painful calcar calcanei diagnosed with X-rays up to six months before. Patients with the following contraindications were excluded from the study: coagulation disorder, anticoagulant use, carcinoma, pregnancy, sensory polyneuropathy, osteoporosis, a pacemaker, acute conditions, lesions of the sole skin, and cortisone treatment up to six weeks before the initial treatment session. Statistical analysis was performed on an “intention to treat” basis, and dropout was not registered.